- Home
- EQBK vs AVDL Comparison
EQBK vs AVDL Comparison
Compare EQBK & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQBK
- AVDL
- Stock Information
- Founded
- EQBK 2002
- AVDL 2015
- Country
- EQBK United States
- AVDL Ireland
- Employees
- EQBK N/A
- AVDL N/A
- Industry
- EQBK Major Banks
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- EQBK Finance
- AVDL Health Care
- Exchange
- EQBK Nasdaq
- AVDL Nasdaq
- Market Cap
- EQBK 750.4M
- AVDL 786.3M
- IPO Year
- EQBK 2015
- AVDL 1996
- Fundamental
- Price
- EQBK $43.12
- AVDL $7.75
- Analyst Decision
- EQBK Hold
- AVDL Strong Buy
- Analyst Count
- EQBK 4
- AVDL 6
- Target Price
- EQBK $44.50
- AVDL $20.00
- AVG Volume (30 Days)
- EQBK 84.6K
- AVDL 1.5M
- Earning Date
- EQBK 01-22-2025
- AVDL 03-03-2025
- Dividend Yield
- EQBK 1.25%
- AVDL N/A
- EPS Growth
- EQBK N/A
- AVDL N/A
- EPS
- EQBK 1.12
- AVDL N/A
- Revenue
- EQBK $157,755,000.00
- AVDL $138,160,000.00
- Revenue This Year
- EQBK N/A
- AVDL $523.86
- Revenue Next Year
- EQBK $6.05
- AVDL $70.46
- P/E Ratio
- EQBK $38.46
- AVDL N/A
- Revenue Growth
- EQBK N/A
- AVDL 1523.50
- 52 Week Low
- EQBK $30.44
- AVDL $7.39
- 52 Week High
- EQBK $50.85
- AVDL $19.09
- Technical
- Relative Strength Index (RSI)
- EQBK 50.11
- AVDL 27.63
- Support Level
- EQBK $39.26
- AVDL $7.39
- Resistance Level
- EQBK $43.27
- AVDL $8.74
- Average True Range (ATR)
- EQBK 1.07
- AVDL 0.48
- MACD
- EQBK 0.28
- AVDL -0.24
- Stochastic Oscillator
- EQBK 85.02
- AVDL 8.72
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. The company's operation involves the delivery of loan and deposit products to customers. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.